The Antibody Series: The Global Reference for Antibody Innovation

The Antibody Series is recognized as the worldwide reference event for antibody discovery and development, setting the benchmark for scientific excellence and innovation. More than just a conference, it is an exclusive, invitation-only gathering where top-tier experts from Industry, Academia, and Venture Capital come together to shape the future of therapeutic antibodies.

With an exquisite and carefully curated program, The Antibody Series offers an unmatched platform for deep scientific exchange, showcasing the most disruptive technologies and breakthrough innovations that are redefining the landscape of antibody engineering, development, and translational science.

Unlike large-scale generalist events, The Antibody Series provides an intimate, high-level environment designed to foster strategic collaboration, ignite game-changing ideas, and facilitate meaningful networking among the true pioneers of the field. Every session is built to challenge conventions, spark forward-thinking discussions, and drive tangible progress.

From AI-powered discovery platforms to next-generation modalities, antibody-drug conjugates, and cutting-edge immunotherapies, The Antibody Series is where science meets technology — and where the future of antibodies is defined.

This is not a typical conference. This is where leaders come together to innovate, collaborate, and inspire.